Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 0

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Assessing mental health, cognitive function and quality of life of breast cancer patients: exploring associations with gut microbiota in an observational and preliminary study

Calafate, Catarina, Alpuim Costa, Diogo, Campos, Teresa, Ribeiro, Pedro Casal, Martinho, Filipa, Freitas, Cristina, Botelho de Sousa, Carolina, Negreiros, Ida, Canastra, Ana, Borralho, Paula, Pereira, Ana Guia, Marçal, Cristina, Ribeiro, Rita, Sousa, José Germano, Dinis, Catarina, Chaleira, Renata, Calha, Rita, Rocha, Júlio César, Calhau, Conceição, Moreira-Rosário, André, Faria, Ana·2026·Frontiers in Psychology
DOI 10.3389/fpsyg.2026.1437697
Open this paper in CoChat — free account

Abstract

Introduction: Breast cancer patients face several physical and psychological problems, such as anxiety, depression, and cognitive dysfunction. The disease and treatments can also impact the microbiota, which is associated with cognitive and psychological issues and, consequently, affected quality-of-life (QoL). This study aimed to correlate the initial gut microbiota of newly diagnosed HR+ (Hormone Receptor)/HER2- breast cancer patients with their mental health, cognitive function, and QoL at baseline and after 3 months of neoadjuvant chemotherapy. Materials and methods: This is a prospective, longitudinal, observational, exploratory study. Newly diagnosed HR+/HER2- breast cancer patients undergoing neoadjuvant chemotherapy were recruited upon diagnosis. At baseline (before neoadjuvant chemotherapy), general and lifestyle information, adherence to the Mediterranean diet, biochemical analysis, gut microbiota profile, the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30 (EORTC QLQ-C30), the Montreal Cognitive Assessment (MoCA) and the Hospital Anxiety and Depression Scale (HADS), were collected. The EORTC QLQ-C30, MoCA, and HADS were repeated 3 months later. Results: From the 11 participants, most showed mild cognitive impairment at baseline, and there was no clear trend of improvement or deterioration at 3 months. Participants had borderline anxiety at baseline, which improved to a normal range, while depression remained stable. QoL declined for most women, with over 70% experiencing problems at 3 months. The association of these parameters with microbiota profile suggested that women with poorer cognitive function over time had lower Shannon index and microbial richness. Women with improved scores in the depression subscale of the HADS appear to have higher Shannon index and lower richness. Contrarily, Shannon index was lower and richness was higher for improved anxiety and global QoL scores. The results also suggest that changes in the abundance of various genera and phyla may be linked to the evolution of scores for the 3 questionnaires. Conclusion: Our study suggests a link between the microbiota profile at diagnosis and the psychological symptoms that develop at 3 months of breast cancer treatment. These findings shed light on potential strategies for positively modulating the microbiota to help enhance the body's resilience, particularly mental health, throughout the disease and treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyg.2026.1437697

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 81

  1. Afonso, 2014, Índices de adesão ao padrão alimentar mediterrânico - a base metodológica para estudar a sua relação com a saúde, Rev. Factores de Risco, 31, 48
  2. Ahmad, 2021, Breast Cancer Metastasis and Drug Resistance Challenges and Progress, 2nd edn
  3. Ahn, 2007, Health-related quality of life in disease-free survivors of breast cancer with the general population, Ann. Oncol, 18, 173, 10.1093/annonc/mdl333 · DOI
  4. Alpuim Costa, 2021, Human microbiota and breast cancer-is there any relevant link?-a literature review and new horizons toward personalised medicine, Front. Microbiol, 12, 584332, 10.3389/fmicb.2021.584332 · DOI
  5. Amarantos, 2001, Nutrition and quality of life in older adults, J. Gerontol. Ser. A, 56, 54, 10.1093/gerona/56.suppl_2.54 · DOI
  6. 2021, Types of Breast Cancer
  7. Araújo, 2021, Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC), Breast, 58, 130, 10.1016/j.breast.2021.05.006 · DOI
  8. Bajic, 2018, From the bottom-up: chemotherapy and gut-brain axis dysregulation, Front. Behav. Neurosci, 12, 104, 10.3389/fnbeh.2018.00104 · DOI · Paper page
  9. Beam, 2021, Effect of diet and dietary components on the composition of the gut microbiota, Nutrients, 13, 2795, 10.3390/nu13082795 · DOI · Paper page
  10. Bower, 2008, Behavioral symptoms in patients with breast cancer and survivors, J. Clin. Oncol, 26, 768, 10.1200/JCO.2007.14.3248 · DOI
  11. Cardoso, 2019, Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann. Oncol, 30, 1194, 10.1093/annonc/mdz173 · DOI · Paper page
  12. Chang, 2022, Brain-gut-microbiota axis in depression: a historical overview and future directions, Brain Res. Bull, 182, 44, 10.1016/j.brainresbull.2022.02.004 · DOI
  13. Ciernikova, 2021, Exploring the potential role of the gut microbiome in chemotherapy-induced neurocognitive disorders and cardiovascular toxicity, Cancers, 13, 782, 10.3390/cancers13040782 · DOI
  14. Coughlin, 2019, “Epidemiology of breast cancer in women,”, Breast Cancer Metastasis and Drug Resistance: Challenges and Progress, 9, 10.1007/978-3-030-20301-6_2 · DOI · Paper page
  15. Crane, 2019, Trajectories of depression and anxiety in latina breast cancer survivors, Oncol. Nurs. Forum, 46, 217
  16. Deleemans, 2022, The chemo-gut pilot study: associations between gut microbiota, gastrointestinal symptoms, and psychosocial health outcomes in a cross-sectional sample of young adult cancer survivors, Curr. Oncol, 29, 2973, 10.3390/curroncol29050243 · DOI
  17. Dijkshoorn, 2021, Prevalence of cognitive impairment and change in patients with breast cancer: a systematic review of longitudinal studies, Psycho. Oncol., 30, 635, 10.1002/pon.5623 · DOI
  18. Dong, 2019, Influence of early life, diet, and the environment on the microbiome, Clin. Gastroenterol. Hepatol, 17, 231, 10.1016/j.cgh.2018.08.067 · DOI
  19. Falleti, 2005, The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature, Brain Cognit, 59, 60, 10.1016/j.bandc.2005.05.001 · DOI
  20. Fayers, 2001, The EORTC QLQ-C30 Scoring Manual, 3rd edn
  21. Fontes, 2016, Prospective study on the neurological complications of breast cancer and its treatment: updated analysis three years after cancer diagnosis, Breast, 29, 31, 10.1016/j.breast.2016.06.013 · DOI
  22. Freitas, 2010, Estudos de adaptação do Montreal Cognitive Assessment (MoCA) para a população portuguesa, Avaliação Psicológica, 9, 345
  23. Härtl, 2010, Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors, Psycho-Oncol, 19, 160, 10.1002/pon.1536 · DOI
  24. Hermelink, 2015, Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain, JNCI Monographs, 2015, 67, 10.1093/jncimonographs/lgv009 · DOI
  25. Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 109, 1905, 10.1002/cncr.22610 · DOI
  26. Iconomou, 2004, Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy, Cancer, 101, 404, 10.1002/cncr.20385 · DOI
  27. Imran, 2019, Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: a tertiary care center survey in the western region of Saudi Arabia, PLoS One, 14, e0219093, 10.1371/journal.pone.0219093 · DOI
  28. Jenkins, 2006, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, Br. J. Cancer, 94, 828, 10.1038/sj.bjc.6603029 · DOI
  29. Juan, 2022, Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial, Eur. J. Cancer, 161, 10, 10.1016/j.ejca.2021.11.006 · DOI · Paper page
  30. Knuesel, 2021, The role of the gut microbiota in the development and progression of major depressive and bipolar disorder, Nutrients, 14, 37, 10.3390/nu14010037 · DOI
  31. Lange, 2019, Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors, Ann. Oncol, 30, 1925, 10.1093/annonc/mdz410 · DOI · Paper page
  32. Li, 2015, Emotional suppression and depressive symptoms in women newly diagnosed with early breast cancer, BMC Women's Health, 15, 91, 10.1186/s12905-015-0254-6 · DOI
  33. Lopes, Prevalence and persistence of anxiety and depression over five years since breast cancer diagnosis-the NEON-BC prospective study, Curr. Oncol, 29, 2141, 10.3390/curroncol29030173 · DOI
  34. Lopes, Trajectories of anxiety and depression symptoms over five years since breast cancer diagnosis: results of the NEON-BC prospective study, Healthcare, 10, 661, 10.3390/healthcare10040661 · DOI
  35. Lopes-Conceição, 2021, Quality of life trajectories during the first three years after diagnosis of breast cancer: the NEON-BC study, J. Public Health, 43, 521, 10.1093/pubmed/fdz159 · DOI
  36. Maitiniyazi, 2022, Impact of gut microbiota on the association between diet and depressive symptoms in breast cancer, Nutrients, 14, 1186, 10.3390/nu14061186 · DOI
  37. McCabe, 2011, “Practice effects,”, Encyclopedia of Clinical Neuropsychology, 1988, 10.1007/978-0-387-79948-3_1139 · DOI
  38. Mokhtari-Hessari, 2020, Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018, Health Qual. Life Outcomes, 18, 338, 10.1186/s12955-020-01591-x · DOI
  39. Montagnese, 2020, Quality of life in women diagnosed with breast cancer after a 12-month treatment of lifestyle modifications, Nutrients, 13, 136, 10.3390/nu13010136 · DOI
  40. Montassier, 2015, Bruley des Varannes S, Massart S, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome, Aliment. Pharmacol. Ther, 42, 515, 10.1111/apt.13302 · DOI
  41. Montazeri, 2008, Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study, BMC Cancer, 8, 330, 10.1186/1471-2407-8-330 · DOI
  42. Moro-Valdezate, 2013, Evolution of health-related quality of life in breast cancer patients during the first year of follow-up, J. Breast Cancer, 16, 104, 10.4048/jbc.2013.16.1.104 · DOI
  43. Nasreddine, 2010, Montreal Cognitive Assessment (MoCA) - Administration and Scoring Instructions
  44. 2021, What Is Cancer?
  45. Nikolova, 2021, Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis, JAMA Psychiatry, 78, 1343, 10.1001/jamapsychiatry.2021.2573 · DOI · Paper page
  46. Noce, 2019, Impact of gut microbiota composition on onset and progression of chronic non-communicable diseases, Nutrients, 11, 1073, 10.3390/nu11051073 · DOI
  47. Okubo, 2020, Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors, Brain Behav. Immunity, 85, 186, 10.1016/j.bbi.2019.02.025 · DOI
  48. Ortega, 2022, Gut microbiota metabolites in major depressive disorder-deep insights into their pathophysiological role and potential translational applications, Metabolites, 12, 50, 10.3390/metabo12010050 · DOI
  49. Pais-Ribeiro, 2008, Validation study of the Portuguese version of the QLC-C30-V.3, Psicologia, Saúde & Doenças, 9, 89
  50. Pais-Ribeiro, 2007, Validation study of a Portuguese version of the hospital anxiety and depression scale, Psychol. Health Med, 12, 225, 10.1080/13548500500524088 · DOI · Paper page
  51. Park, 2021, Health-related quality of life outcomes among breast cancer survivors, Cancer, 127, 1114, 10.1002/cncr.33348 · DOI
  52. Paulsen, 2017, Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors, Supp. Care Cancer, 25, 1563, 10.1007/s00520-016-3568-5 · DOI
  53. Pereira, 2015, Neurological complications of breast cancer: a prospective cohort study, Breast, 24, 582, 10.1016/j.breast.2015.05.006 · DOI
  54. Porciello, 2020, Mediterranean diet and quality of life in women treated for breast cancer: a baseline analysis of DEDiCa multicentre trial, PLoS One, 15, e0239803, 10.1371/journal.pone.0239803 · DOI
  55. Ramalho, 2017, Cognitive impairment in the first year after breast cancer diagnosis: a prospective cohort study, Breast, 32, 173, 10.1016/j.breast.2017.01.018 · DOI
  56. Rodríguez Martín, 2020, Study of chemotherapy-induced cognitive impairment in women with breast cancer, Int. J. Environ. Res. Public Health, 17, 8896, 10.3390/ijerph17238896 · DOI
  57. Rojas, 2016, Breast cancer epidemiology and risk factors, Clin. Obstet. Gynecol, 59, 651, 10.1097/GRF.0000000000000239 · DOI
  58. Roy, 2017, Microbiota: a key orchestrator of cancer therapy, Nat. Rev. Cancer, 17, 271, 10.1038/nrc.2017.13 · DOI · Paper page
  59. Sampsell, 2020, The gut microbiota: a potential gateway to improved health outcomes in breast cancer treatment and survivorship, Int. J. Mol. Sci, 21, 9239, 10.3390/ijms21239239 · DOI
  60. Shreiner, 2015, The gut microbiome in health and in disease, Curr. Opin. Gastroenterol, 31, 69, 10.1097/MOG.0000000000000139 · DOI
  61. Simpson, 2021, The gut microbiota in anxiety and depression—a systematic review, Clin. Psychol. Rev, 83, 101943, 10.1016/j.cpr.2020.101943 · DOI · Paper page
  62. Singh, 2017, Influence of diet on the gut microbiome and implications for human health, J. Transl. Med, 15, 73, 10.1186/s12967-017-1175-y · DOI · Paper page
  63. Smith, 2015, Depression in cancer patients: pathogenesis, implications and treatment (Review), Oncol. Lett, 9, 1509, 10.3892/ol.2015.2944 · DOI
  64. Smith, 2022, Health-related quality of life is associated with fecal microbial composition in breast cancer survivors, Supp. Care Cancer, 31, 10, 10.1007/s00520-022-07496-3 · DOI
  65. Stark, 2000, Anxiety in cancer patients, Br. J. Cancer, 83, 1261, 10.1054/bjoc.2000.1405 · DOI · Paper page
  66. Stewart, 2006, Meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer, Clin. Neuropsychol, 20, 76, 10.1080/138540491005875 · DOI
  67. Stewart, 2008, The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study, Psycho. Oncol, 17, 122, 10.1002/pon.1210 · DOI
  68. Subramaniam, 2020, The microbiota-gut-brain axis: an emerging therapeutic target in chemotherapy-induced cognitive impairment, Neurosci. Biobehav. Rev, 116, 470, 10.1016/j.neubiorev.2020.07.002 · DOI · Paper page
  69. Thu, 2023, Effect of probiotics in breast cancer: a systematic review and meta-analysis, Biology, 12, 280, 10.3390/biology12020280 · DOI
  70. Tooley, 2020, Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review, Nutrients, 12, 3009, 10.3390/nu12103009 · DOI
  71. Traore, 2018, Evolution of quality of life in patients with breast cancer during the first year of follow-up in Morocco, BMC Cancer, 18, 109, 10.1186/s12885-018-4008-3 · DOI
  72. Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat. Microbiol., 4, 623, 10.1038/s41564-018-0337-x · DOI · Paper page
  73. Veronesi, 2005, Breast cancer, Lancet, 365, 1727, 10.1016/S0140-6736(05)66546-4 · DOI
  74. Villéger, 2019, Intestinal microbiota: a novel target to improve anti-tumor treatment?, Int. J. Mol. Sci, 20, 4584, 10.3390/ijms20184584 · DOI
  75. Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol, 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI
  76. Winters, 2017, “Chapter one-breast cancer epidemiology, prevention, and screening,”, Progress in Molecular Biology and Translational Science, Vol. 151, 1, 10.1016/bs.pmbts.2017.07.002 · DOI · Paper page
  77. 2020, Cancer Today
  78. 2021, Breast Cancer
  79. Yang, 2017, Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications, Breast Cancer, 24, 220, 10.1007/s12282-016-0734-z · DOI
  80. Zhang, 2018, Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy, Cancer Nurs, 41, 62, 10.1097/NCC.0000000000000451 · DOI
  81. Zhu, 2021, Altered fecal microbiota signatures in patients with anxiety and depression in the gastrointestinal cancer screening: a case-control study, Front. Psychiatry, 12, 757139, 10.3389/fpsyt.2021.757139 · DOI

Metadata

Authors
Calafate, C., Alpuim Costa, D., Campos, T., Ribeiro, P. C., Martinho, F., Freitas, C., Botelho de Sousa, C., Negreiros, I., Canastra, A., Borralho, P., Pereira, A. G., Marçal, C., Ribeiro, R., Sousa, J. G., Dinis, C., Chaleira, R., Calha, R., Rocha, J. C., Calhau, C., Moreira-Rosário, A., & Faria, A.
Venue
Frontiers in Psychology
Publisher
Frontiers Media SA
Published
2026-03-11
Volume
17
ISSN
1664-1078
DOI
10.3389/fpsyg.2026.1437697
Cited by
0
References
10
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.